Literature DB >> 7684650

Relationship between prostate specific antigen, prostate volume and age in the benign prostate.

G N Collins1, R J Lee, G B McKelvie, A C Rogers, M Hehir.   

Abstract

The relationship between prostate specific antigen (PSA) levels, prostate volume and age was examined in 472 men who underwent PSA assay (Hybritech), digital rectal examination (DRE) and transrectal ultrasound (TRUS) as part of a community survey of benign prostatic hyperplasia following exclusion of men with prostate cancer. The mean age of the study population was 60 years (range 40-79). The mean PSA was 2.4 ng/ml and 85% of the men had levels < 4 ng/ml. There was a modest correlation between PSA and both age and prostate volume. The mean prostate and adenoma volumes were 32 ml (SD 13.4) and 15 ml (SD 10.7) respectively. Prostate volume increased with age. Linear regression analysis revealed an independent association between PSA and age when controlling for volume. The mean ratio of PSA per unit of prostate volume was 0.072 ng/ml. This ratio also increased with age. Age and prostate volume influences PSA levels independently. The sensitivity and specificity of PSA adjusted for volume and age in the diagnosis of prostate cancer need to be evaluated in association with DRE and TRUS.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7684650     DOI: 10.1111/j.1464-410x.1993.tb15990.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  24 in total

1.  Relationship between prostate-specific antigen, prostate volume, retention volume and age in benign prostatic hypertrophy (BPH).

Authors:  S Dutkiewicz; A Witeska; K Stepień
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

2.  Association between serum prostate-specific antigen level and diabetes, obesity, hypertension, and the laboratory parameters related to glucose tolerance, hepatic function, and lipid profile: implications for modification of prostate-specific antigen threshold.

Authors:  Minoru Kobayashi; Tomoya Mizuno; Hideo Yuki; Tsunehito Kambara; Hironori Betsunoh; Akinori Nukui; Hideyuki Abe; Yoshitatsu Fukabori; Masahiro Yashi; Takao Kamai
Journal:  Int J Clin Oncol       Date:  2019-08-22       Impact factor: 3.402

3.  Associations between variants in the cyclooxygenase 2 enzyme gene (PTGS2) and development of benign prostate enlargement.

Authors:  Jennifer L St Sauver; Michael M Lieber; Susan L Slager; Debra J Jacobson; Michaela E McGree; Steven J Jacobsen
Journal:  BJU Int       Date:  2011-04-11       Impact factor: 5.588

4.  Population standards of prostate specific antigen values in men over 40: community based study in Turkey.

Authors:  Talha Müezzinoğlu; Murat Lekili; Erhan Eser; Bekir S Uyanik; Coşkun Büyüksu
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

5.  Challenging the Inevitability of Prostate Enlargement: Low Levels of Benign Prostatic Hyperplasia Among Tsimane Forager-Horticulturalists.

Authors:  Benjamin C Trumble; Jonathan Stieglitz; Daniel Eid Rodriguez; Edhitt Cortez Linares; Hillard S Kaplan; Michael D Gurven
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-04-28       Impact factor: 6.053

6.  Age-related changes in prostate zonal volumes as measured by high-resolution magnetic resonance imaging (MRI): a cross-sectional study in over 500 patients.

Authors:  Baris Turkbey; Robert Huang; Srinivas Vourganti; Hari Trivedi; Marcelino Bernardo; Pingkun Yan; Compton Benjamin; Peter A Pinto; Peter L Choyke
Journal:  BJU Int       Date:  2012-09-14       Impact factor: 5.588

7.  Does an asymmetric lobe in digital rectal examination include any risk for prostate cancer? results of 1495 biopsies.

Authors:  Ömer Yilmaz; Özgür Kurul; Ferhat Ates; Hasan Soydan; Zeki Aktas
Journal:  Int Braz J Urol       Date:  2016 Jul-Aug       Impact factor: 1.541

8.  Prostate specific antigen versus prostate specific antigen density as a prognosticator of pathological characteristics and biochemical recurrence following radical prostatectomy.

Authors:  Ahmed Magheli; Soroush Rais-Bahrami; Bruce J Trock; Elizabeth B Humphreys; Alan W Partin; Misop Han; Mark L Gonzalgo
Journal:  J Urol       Date:  2008-03-17       Impact factor: 7.450

9.  Serum prostate-specific antigen as a predictor of prostate volume and lower urinary tract symptoms in a community-based cohort: a large-scale Korean screening study.

Authors:  Dong Soo Park; Jong Jin Oh; Jae Yup Hong; Young Kwon Hong; Don Kyung Choi; In Hyuck Gong; Jin Ho Hwang; Sung Won Kwon
Journal:  Asian J Androl       Date:  2013-01-28       Impact factor: 3.285

10.  Associations between C-reactive protein and benign prostatic hyperplasia/lower urinary tract symptom outcomes in a population-based cohort.

Authors:  Jennifer L St Sauver; Aruna V Sarma; Debra J Jacobson; Michaela E McGree; Michael M Lieber; Cynthia J Girman; Ajay Nehra; Steven J Jacobsen
Journal:  Am J Epidemiol       Date:  2009-04-24       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.